Pallas Capital Advisors »

Myriad Genetics shares owned by Pallas Capital Advisors

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Pallas Capital Advisors from 13F filings

Historical chart of Pallas Capital Advisors investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Pallas Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Pallas Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $80k 13k 6.15
2025-06-30 $57k 11k 5.31

More positions owned by Pallas Capital Advisors

Bruker Corporation (BRKR)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Microsoft Corporation (MSFT)
Global Partners Com Units (GLP)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Schwab Strategic Tr Fundamental Intl (FNDF)
Dimensional Etf Trust Internatnal Val (DFIV)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Broadcom (AVGO)
Fidelity Covington Trust Enhanced Intl (FENI)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)

View all positions for Pallas Capital Advisors

Top funds holding Myriad Genetics

BlackRock
Vanguard Group
State Street Corporation
Millennium Management
Glenview Captal Management
D. E. Shaw & Co
Jacobs Levy Equity Management
Geode Capital Management
Goldman Sachs Group
Charles Schwab Investment Management
AQR Capital Management
Federated Investors
Dimensional Fund Advisors
Point72 Asset Management
Vestal Point Capital

View all funds holding Myriad Genetics